BlackRock Institutional Trust Company, N.A. - RXI PHARMACEUTICALS CORP NEW ownership

Back to all holdings Add to watchlist

RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 17 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q4 2016$8,000
-60.0%
10,8770.0%0.00%–
Q3 2016$20,000
-23.1%
10,8770.0%0.00%–
Q2 2016$26,000–10,877–0.00%–
 Download
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q4 2016
NameSharesValueWeighting ↓
Intellectus Partners, LLC 20,000$11,0000.00%
TWO SIGMA SECURITIES, LLC 42,209$23,0000.00%
Virtu Financial LLC 25,413$14,0000.00%
VANGUARD GROUP INC 17,974$10,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 9$00.00%
UBS Group AG 15,341$9,0000.00%
Advisor Group, Inc. 196$00.00%
BANK OF AMERICA CORP /DE/ 650$00.00%
NORTHERN TRUST CORP 11,721$7,0000.00%
DEUTSCHE BANK AG\ 2$00.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders